• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与血浆胆固醇水平相关的生物分子冠稳定性

Biomolecular Corona Stability in Association with Plasma Cholesterol Level.

作者信息

Trinh Duong N, Radlinskaite Meda, Cheeseman Jack, Kuhnle Gunter, Osborn Helen M I, Meleady Paula, Spencer Daniel I R, Monopoli Marco P

机构信息

Department of Chemistry, Royal College of Surgeons in Ireland, RCSI University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.

School of Physics & Clinical & Optometric Sciences, Technological University Dublin, D07 EWV4 Dublin, Ireland.

出版信息

Nanomaterials (Basel). 2022 Aug 3;12(15):2661. doi: 10.3390/nano12152661.

DOI:10.3390/nano12152661
PMID:35957093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9370777/
Abstract

Biomolecular corona is spontaneously formed on the surface of nanoparticles (NPs) when they are in contact with biological fluids. It plays an important role in the colloidal stability of NPs, which is of importance for most of their medical applications and toxicity assessment. While typical studies use either blood plasma or serum from a pooled biobank, it is unclear whether differences in the media, such as cholesterol level or protein concentration, might affect the NP colloidal stability and corona composition. In this study, the silica corona was prepared at particularly low plasma concentrations (3%, /-1.98 mg/mL) to identify the critical roles of the protein mass/NP surface ratio and the level of plasma cholesterol on the corona protein pattern and particle stability. While depending on the plasma dilution factor, the corona protein composition could be controlled by keeping the protein/NP constant. The NP colloidal stability was found to strongly correlate with the level of cholesterol in human plasma, particularly due to the high enrichment of high-density lipoprotein (HDL) and low-density lipoprotein (LDL) in the corona. A cohort study on plasma samples from individuals with known cholesterol levels was performed to highlight that association, which could be relevant for all corona systems enriched with the LDL.

摘要

当纳米颗粒(NPs)与生物流体接触时,生物分子冠会自发形成于其表面。它在NPs的胶体稳定性中起着重要作用,这对其大多数医学应用和毒性评估都很重要。虽然典型研究使用来自集中生物样本库的血浆或血清,但尚不清楚诸如胆固醇水平或蛋白质浓度等介质差异是否会影响NP胶体稳定性和冠层组成。在本研究中,以特别低的血浆浓度(3%,±1.98 mg/mL)制备二氧化硅冠层,以确定蛋白质质量/NP表面比和血浆胆固醇水平对冠层蛋白质模式和颗粒稳定性的关键作用。虽然取决于血浆稀释因子,但通过保持蛋白质/NP恒定可以控制冠层蛋白质组成。发现NP胶体稳定性与人体血浆中的胆固醇水平密切相关,特别是由于冠层中高密度脂蛋白(HDL)和低密度脂蛋白(LDL)的高度富集。对来自已知胆固醇水平个体的血浆样本进行了队列研究,以突出这种关联,这可能与所有富含LDL的冠层系统相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/99875002c6c5/nanomaterials-12-02661-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/7fc027f166f9/nanomaterials-12-02661-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/42cf1e7764fa/nanomaterials-12-02661-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/18fc586f2070/nanomaterials-12-02661-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/5738d608fd85/nanomaterials-12-02661-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/93d54947049c/nanomaterials-12-02661-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/99875002c6c5/nanomaterials-12-02661-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/7fc027f166f9/nanomaterials-12-02661-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/42cf1e7764fa/nanomaterials-12-02661-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/18fc586f2070/nanomaterials-12-02661-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/5738d608fd85/nanomaterials-12-02661-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/93d54947049c/nanomaterials-12-02661-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/9370777/99875002c6c5/nanomaterials-12-02661-g006.jpg

相似文献

1
Biomolecular Corona Stability in Association with Plasma Cholesterol Level.与血浆胆固醇水平相关的生物分子冠稳定性
Nanomaterials (Basel). 2022 Aug 3;12(15):2661. doi: 10.3390/nano12152661.
2
In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.荧光相关光谱法原位表征蛋白质在纳米颗粒上的吸附。
Acc Chem Res. 2017 Feb 21;50(2):387-395. doi: 10.1021/acs.accounts.6b00579. Epub 2017 Feb 1.
3
Size Dependence Unveiling the Adsorption Interaction of High-Density Lipoprotein Particles with PEGylated Gold Nanoparticles in Biomolecular Corona Formation.尺寸依赖性揭示高密度脂蛋白颗粒与聚乙二醇化金纳米粒子在生物分子冠形成中的吸附相互作用。
Langmuir. 2021 Aug 17;37(32):9755-9763. doi: 10.1021/acs.langmuir.1c01182. Epub 2021 Aug 4.
4
The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.为体外蛋白质冠层分析选择合适生物环境的重要性:人血浆与人血清的比较。
Int J Biochem Cell Biol. 2016 Jun;75:188-95. doi: 10.1016/j.biocel.2015.11.019. Epub 2015 Nov 28.
5
Protein Corona Formed from Different Blood Plasma Proteins Affects the Colloidal Stability of Nanoparticles Differently.不同血浆蛋白形成的蛋白质冠对纳米颗粒的胶体稳定性的影响不同。
Bioconjug Chem. 2018 Nov 21;29(11):3923-3934. doi: 10.1021/acs.bioconjchem.8b00743. Epub 2018 Oct 29.
6
Effect of the protein corona on the colloidal stability and reactivity of LDH-based nanocarriers.蛋白质冠层对基于层状双氢氧化物的纳米载体的胶体稳定性和反应活性的影响。
J Mater Chem B. 2016 Mar 21;4(11):2008-2016. doi: 10.1039/c5tb02698a. Epub 2016 Feb 26.
7
Biomolecular corona formation: nature and bactericidal impact on surface-modified silica nanoparticles.生物分子冠层的形成:对表面改性二氧化硅纳米颗粒的性质及杀菌影响
J Mater Chem B. 2017 Oct 28;5(40):8052-8059. doi: 10.1039/c7tb01744h. Epub 2017 Sep 12.
8
Probing the glycans accessibility in the nanoparticle biomolecular corona.探究纳米颗粒生物分子冠层中聚糖的可及性。
J Colloid Interface Sci. 2022 May;613:563-574. doi: 10.1016/j.jcis.2021.11.140. Epub 2021 Dec 16.
9
Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood.个体特异性生物分子冠调节纳米颗粒与人血液中免疫细胞的相互作用。
ACS Nano. 2020 Nov 24;14(11):15723-15737. doi: 10.1021/acsnano.0c06679. Epub 2020 Oct 28.
10
An environmental route of exposure affects the formation of nanoparticle coronas in blood plasma.环境暴露途径会影响血浆中纳米颗粒冠层的形成。
J Proteomics. 2016 Mar 30;137:52-8. doi: 10.1016/j.jprot.2015.10.028. Epub 2015 Nov 9.

引用本文的文献

1
Multiple Exposures of Plasma to Nanoparticles: A Novel Tool to Personalize Biomolecular Coronas and Fractionate Fluids.血浆对纳米颗粒的多次暴露:一种个性化生物分子冠层和分离流体的新工具。
Anal Chem. 2025 Jul 15;97(27):14132-14141. doi: 10.1021/acs.analchem.4c05573. Epub 2025 Jun 30.
2
Biocorona on Iron Oxide Nanoparticles in a Complex Biotechnological Environment: Analysis of Proteins, Lipids, and Carbohydrates.复杂生物技术环境中氧化铁纳米颗粒上的生物冠:蛋白质、脂质和碳水化合物分析
Small Sci. 2023 Jul 9;3(9):2300064. doi: 10.1002/smsc.202300064. eCollection 2023 Sep.
3
Understanding the role of biomolecular coronas in human exposure to nanomaterials.

本文引用的文献

1
Nanoparticle Biomolecular Corona-Based Enrichment of Plasma Glycoproteins for N-Glycan Profiling and Application in Biomarker Discovery.基于纳米颗粒生物分子冠的血浆糖蛋白富集用于 N-糖谱分析及其在生物标志物发现中的应用。
ACS Nano. 2022 Apr 26;16(4):5463-5475. doi: 10.1021/acsnano.1c09564. Epub 2022 Mar 28.
2
Probing the glycans accessibility in the nanoparticle biomolecular corona.探究纳米颗粒生物分子冠层中聚糖的可及性。
J Colloid Interface Sci. 2022 May;613:563-574. doi: 10.1016/j.jcis.2021.11.140. Epub 2021 Dec 16.
3
Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol.
了解生物分子冠层在人类接触纳米材料中的作用。
Environ Sci Nano. 2024 Sep 9;11(11):4421-4448. doi: 10.1039/d4en00488d. eCollection 2024 Nov 7.
4
Protocols for isolation and characterization of nanoparticle biomolecular corona complexes.纳米颗粒生物分子冠冕复合物的分离与表征方案。
Front Toxicol. 2024 Jul 23;6:1393330. doi: 10.3389/ftox.2024.1393330. eCollection 2024.
降低低密度脂蛋白胆固醇的新型非他汀类治疗选择
Front Cardiovasc Med. 2021 Nov 17;8:789931. doi: 10.3389/fcvm.2021.789931. eCollection 2021.
4
Current understanding of biological identity at the nanoscale and future prospects.当前对纳米尺度生物同一性的理解和未来展望。
Nat Nanotechnol. 2021 Mar;16(3):229-242. doi: 10.1038/s41565-021-00860-0. Epub 2021 Feb 17.
5
Opsonins and Dysopsonins of Nanoparticles: Facts, Concepts, and Methodological Guidelines.纳米颗粒的调理蛋白和去调理蛋白:事实、概念和方法学指南。
Front Immunol. 2020 Oct 12;11:567365. doi: 10.3389/fimmu.2020.567365. eCollection 2020.
6
Personalized Graphene Oxide-Protein Corona in the Human Plasma of Pancreatic Cancer Patients.胰腺癌患者人血浆中的个性化氧化石墨烯-蛋白质冠层
Front Bioeng Biotechnol. 2020 May 25;8:491. doi: 10.3389/fbioe.2020.00491. eCollection 2020.
7
Personalized protein coronas: a "key" factor at the nanobiointerface.个性化蛋白质冠层:纳米生物界面的“关键”因素。
Biomater Sci. 2014 Sep 29;2(9):1210-1221. doi: 10.1039/c4bm00131a. Epub 2014 May 30.
8
Pay Attention to Biological Nanoparticles when Studying the Protein Corona on Nanomedicines.研究纳米药物上的蛋白冠时要注意生物纳米颗粒。
Angew Chem Int Ed Engl. 2020 Jul 27;59(31):12584-12588. doi: 10.1002/anie.202004611. Epub 2020 Jun 8.
9
Identification of physicochemical properties that modulate nanoparticle aggregation in blood.调节纳米颗粒在血液中聚集的物理化学性质的鉴定。
Beilstein J Nanotechnol. 2020 Apr 3;11:550-567. doi: 10.3762/bjnano.11.44. eCollection 2020.
10
Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles.了解不同粒径的聚合物纳米颗粒上的脂质和蛋白质冠的形成。
Sci Rep. 2020 Jan 24;10(1):1129. doi: 10.1038/s41598-020-57943-6.